These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1607 related items for PubMed ID: 28659128
21. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer. Smithers BM, Thomson I. Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701 [Abstract] [Full Text] [Related]
23. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery. Reisinger KW, Bosmans JW, Uittenbogaart M, Alsoumali A, Poeze M, Sosef MN, Derikx JP. Ann Surg Oncol; 2015 Dec; 22(13):4445-52. PubMed ID: 25893413 [Abstract] [Full Text] [Related]
24. Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer. Shaikh T, Thomay A, Ruth K, Cohen SJ, Meyer JE. J Surg Oncol; 2015 Nov; 112(6):629-33. PubMed ID: 26430952 [Abstract] [Full Text] [Related]
33. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis. Nomura M, Oze I, Kodaira T, Abe T, Komori A, Narita Y, Masuishi T, Taniguchi H, Kadowaki S, Ura T, Andoh M, Tachibana H, Uemura N, Tajika M, Niwa Y, Muto M, Muro K. Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212 [Abstract] [Full Text] [Related]
34. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E. Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952 [Abstract] [Full Text] [Related]
37. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation. Gabriel E, Attwood K, Du W, Tuttle R, Alnaji RM, Nurkin S, Malhotra U, Hochwald SN, Kukar M. JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488 [Abstract] [Full Text] [Related]
39. Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma. Ma HB, Di ZL, Wen J, Ke Y, Sun X, Ren J. Jpn J Clin Oncol; 2015 Feb; 45(2):169-75. PubMed ID: 25416813 [Abstract] [Full Text] [Related]